Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine
2. Cinarizina Inkey
3. Cinarizina Ratiopharm
4. Cinarizine
5. Cinazire
6. Cinna
7. Cinnarizin Al
8. Cinnarizin Ratiopharm
9. Cinnarizin Siegfried
10. Cinnarizin Von Ct
11. Cinnarizin-ratiopharm
12. Cinnarizine L Tartrate
13. Cinnarizine L-tartrate
14. Cinnarizine L-tartrate (1:1)
15. Cinnarizine, (e)-isomer
16. Cinnarizine, Dihydrochloride
17. Cinnipirine
18. Cisaken
19. Dihydrochloride Cinnarizine
20. Dimitronal
21. L-tartrate, Cinnarizine
22. R 516
23. R-516
24. R516
25. Stugeron
26. Stugeron Forte
27. Von Ct, Cinnarizin
1. 298-57-7
2. Stugeron
3. Stutgin
4. Cinarizine
5. Dimitronal
6. Stutgeron
7. Dimitron
8. Folcodal
9. Labyrin
10. Midronal
11. Mitronal
12. Glanil
13. Sepan
14. Cinazyn
15. Aplactan
16. Cinnageron
17. Lazeta
18. Marisan
19. Toliman
20. Cinaperazine
21. Cinnipirine
22. Cerepar
23. Cinnarizinum
24. Cerebolan
25. Cinarizina
26. Cinnacet
27. Corathiem
28. Giganten
29. Hilactan
30. Katoseran
31. Processine
32. Sedatromin
33. Siptazin
34. Spaderizine
35. Aplexal
36. Artate
37. Carecin
38. Denapol
39. Ixertol
40. Olamin
41. Eglen
42. 1-benzhydryl-4-cinnamylpiperazine
43. 16699-20-0
44. R 516
45. 1-cinnamyl-4-(diphenylmethyl)piperazine
46. R 1575
47. 516 Md
48. Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-
49. 1-benzhydryl-4-cinnamylpiperazin
50. 1-benzhydryl-4-[(e)-3-phenylprop-2-enyl]piperazine
51. Stunarone
52. 1-(diphenylmethyl)-4-[(2e)-3-phenylprop-2-en-1-yl]piperazine
53. (e)-1-benzhydryl-4-cinnamylpiperazine
54. 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine
55. R-516
56. 1-trans-cinnamyl-4-diphenylmethylpiperazine
57. 1-benzhydryl-4-[(e)-cinnamyl]piperazine
58. Chembl43064
59. Mls000028498
60. 3di2e1x18l
61. Piperazine, 1-cinnamyl-4-(diphenylmethyl)-
62. Chebi:31403
63. R-1575
64. 516-md
65. Nsc-758400
66. 1-(diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)piperazine
67. Libotasin
68. Senoger
69. Smr000058307
70. Votegol
71. Zepamol
72. Cero-aterin
73. Dsstox_cid_2821
74. Dsstox_rid_76744
75. Dsstox_gsid_22821
76. Cinarizina [inn-spanish]
77. Cinnarizinum [inn-latin]
78. Apotomin
79. Stonoron
80. Cinnarizine [usan:inn:ban:jan]
81. Sr-01000003093
82. Einecs 206-064-8
83. Md 516
84. Brn 0626121
85. Unii-3di2e1x18l
86. Cinnarizine (jan/usan/inn)
87. 1-cinnamyl-4-diphenylmethylpiperazine
88. N-benzhydryl-n'-cinnamylpiperazine
89. Ncgc00015246-02
90. 1185242-27-6
91. Cas-298-57-7
92. Cinnarizine, Powder
93. Prestwick_115
94. Mfcd00056037
95. Piperazine, (e)-
96. Cinnarizine [mi]
97. Opera_id_1776
98. Prestwick2_000278
99. Prestwick3_000278
100. Cinnarizine [inn]
101. Cinnarizine [jan]
102. 1-(diphenylmethyl)-4-(3-phenylprop-2-enyl)piperazine
103. Cinnarizine [usan]
104. C 5270
105. Cinnarizine [mart.]
106. Lopac0_000314
107. Schembl44957
108. Schembl44958
109. Bspbio_000156
110. Cinnarizine [who-dd]
111. Mls001148649
112. Mls002207295
113. Mls002222167
114. Bpbio1_000172
115. Gtpl9072
116. 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine
117. Cid_1547484
118. Cinnarizine [ep Impurity]
119. Dtxsid80859311
120. Chebi:131176
121. 4-((2e)-3-phenylprop-2-enyl)-1-(diphenylmethyl)piperazine
122. Cinnarizine [ep Monograph]
123. Hms1568h18
124. Hms2095h18
125. Hms2234b20
126. Hms3260p10
127. Hms3712h18
128. Hms3885f20
129. Component Of Emesazine (salt/mix)
130. Hy-b1090
131. Tox21_110109
132. Tox21_500314
133. Bdbm50017657
134. Nsc290687
135. Nsc771642
136. Stk216257
137. Zinc19632891
138. Akos002134299
139. Stugeron
140. Dimitronal
141. Stutgin
142. Cinarizine
143. Tox21_110109_1
144. Ccg-204409
145. Cs-4656
146. Ks-5155
147. Lp00314
148. Nsc 758400
149. Nsc-290687
150. Nsc-771642
151. Sdccgsbi-0050302.p002
152. Qtl1_000023
153. Ncgc00018187-03
154. Ncgc00018187-04
155. Ncgc00018187-05
156. Ncgc00018187-06
157. Ncgc00018187-07
158. Ncgc00018187-09
159. Ncgc00018187-14
160. Ncgc00021488-03
161. Ncgc00021488-04
162. Ncgc00021488-05
163. Ncgc00260999-01
164. Bc167081
165. Ls-15144
166. Eu-0100314
167. S4727
168. A16455
169. D01295
170. D89561
171. 298c577
172. A820077
173. L001227
174. Q775073
175. 1-benzhydryl-4-[3-phenyl-2-propenyl]piperazine #
176. Sr-01000003093-2
177. Sr-01000003093-6
178. W-106970
179. W-110442
180. 1-benzhydryl-4-[(2e)-3-phenylprop-2-enyl]piperazine
181. Brd-k07220430-001-03-6
182. Brd-k74927006-001-01-2
183. 1-[di(phenyl)methyl]-4-(3-phenylprop-2-enyl)piperazine
184. 1-(diphenylmethyl)-4-(3-phenylprop-2-en-1-yl)piperazine
185. Cinnarizine, European Pharmacopoeia (ep) Reference Standard
186. Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)-
187. N90
| Molecular Weight | 368.5 g/mol |
|---|---|
| Molecular Formula | C26H28N2 |
| XLogP3 | 5.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Exact Mass | 368.225248902 g/mol |
| Monoisotopic Mass | 368.225248902 g/mol |
| Topological Polar Surface Area | 6.5 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 429 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
N - Nervous system
N07 - Other nervous system drugs
N07C - Antivertigo preparations
N07CA - Antivertigo preparations
N07CA02 - Cinnarizine
Cinnarizine has known human metabolites that include 1-Benzhydrylpiperazine, 1-Cinnamylpiperazine, 4-{3-[4-(diphenylmethyl)piperazin-1-yl]prop-1-en-1-yl}phenol, 4-{phenyl[4-(3-phenylprop-2-en-1-yl)piperazin-1-yl]methyl}phenol, Benzophenone, and Cinnamaldehyde.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
API SUPPLIERS
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Jai Radhe Sales is your partner for all your sourcing needs.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31934
Submission : 2017-09-07
Status : Active
Type : II
Certificate Number : CEP 2003-150 - Rev 04
Issue Date : 2025-04-07
Type : Chemical
Substance Number : 816
Status : Valid
Date of Issue : 2022-06-18
Valid Till : 2025-07-07
Written Confirmation Number : WC-0055n
Address of the Firm :
NDC Package Code : 55545-0702
Start Marketing Date : 2017-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Certificate Number : R0-CEP 2019-080 - Rev 01
Issue Date : 2023-02-03
Type : Chemical
Substance Number : 816
Status : Valid
Date of Issue : 2024-06-25
Valid Till : 2027-04-16
Written Confirmation Number : WC-0287
Address of the Firm :
Certificate Number : R0-CEP 2001-130 - Rev 01
Issue Date : 2004-12-03
Type : Chemical
Substance Number : 816
Status : Expired
Certificate Number : R2-CEP 1994-016 - Rev 03
Issue Date : 2011-10-27
Type : Chemical
Substance Number : 816
Status : Valid
Certificate Number : CEP 2015-019 - Rev 01
Issue Date : 2025-05-07
Type : Chemical
Substance Number : 816
Status : Valid
Date of Issue : 2022-08-16
Valid Till : 2025-08-13
Written Confirmation Number : WC-0229
Address of the Firm :
Certificate Number : R1-CEP 2004-271 - Rev 04
Issue Date : 2022-09-07
Type : Chemical
Substance Number : 816
Status : Valid
Date of Issue : 2022-06-08
Valid Till : 2025-07-02
Written Confirmation Number : WC-0094n
Address of the Firm :
Date of Issue : 2022-06-14
Valid Till : 2025-07-02
Written Confirmation Number : WC-0094nA2A
Address of the Firm :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31934
Submission : 2017-09-07
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Certificate Number : CEP 2003-150 - Rev 04
Status : Valid
Issue Date : 2025-04-07
Type : Chemical
Substance Number : 816
Certificate Number : CEP 2015-019 - Rev 01
Status : Valid
Issue Date : 2025-05-07
Type : Chemical
Substance Number : 816
Certificate Number : R1-CEP 2004-271 - Rev 04
Status : Valid
Issue Date : 2022-09-07
Type : Chemical
Substance Number : 816
Certificate Number : R2-CEP 1994-016 - Rev 03
Status : Valid
Issue Date : 2011-10-27
Type : Chemical
Substance Number : 816
Certificate Number : R0-CEP 2001-130 - Rev 01
Status : Expired
Issue Date : 2004-12-03
Type : Chemical
Substance Number : 816
Certificate Number : R0-CEP 2019-080 - Rev 01
Status : Valid
Issue Date : 2023-02-03
Type : Chemical
Substance Number : 816
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
NDC Package Code : 55545-0702
Start Marketing Date : 2017-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Jai Radhe Sales is your partner for all your sourcing needs.
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
About the Company : FDC continues to uphold the pioneering spirit of its founding vision, achieving accreditations from esteemed regulatory bodies such as the US-FDA, UK-MHRA, MCC-RSA, and UAE authori...
About the Company : Fleming Laboratories Limited is in the business of manufacturing and supply of high-quality generic Active Pharmaceutical Ingredients (APIs) to the global Pharmaceutical Industry. ...
About the Company : Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharma...
About the Company : Rakshit is an integrated API manufacturing company. Established in 2000. Today Rakshit has emerged a dependable and strong manufacturer of key APIs & intermediates for global marke...
About the Company : RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor si...
About the Company : VASUDHA PHARMA CHEM LIMITED was incorporated, as a public limited company under the Companies Act, 1956 in 1994-95 at Hyderabad in the state of Telangana, India. The company is eng...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
APIs
Reply
26 May 2023
Reply
20 May 2023
Reply
23 Mar 2023
Reply
22 Nov 2022
Reply
21 Mar 2022
Reply
23 Dec 2021
Reply
29 Jul 2021
Reply
15 Jun 2020
Reply
28 Aug 2019
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
51
PharmaCompass offers a list of Cinnarizine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cinnarizine manufacturer or Cinnarizine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cinnarizine manufacturer or Cinnarizine supplier.
PharmaCompass also assists you with knowing the Cinnarizine API Price utilized in the formulation of products. Cinnarizine API Price is not always fixed or binding as the Cinnarizine Price is obtained through a variety of data sources. The Cinnarizine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Alpharma Brand of Cinnarizine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alpharma Brand of Cinnarizine, including repackagers and relabelers. The FDA regulates Alpharma Brand of Cinnarizine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alpharma Brand of Cinnarizine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alpharma Brand of Cinnarizine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alpharma Brand of Cinnarizine supplier is an individual or a company that provides Alpharma Brand of Cinnarizine active pharmaceutical ingredient (API) or Alpharma Brand of Cinnarizine finished formulations upon request. The Alpharma Brand of Cinnarizine suppliers may include Alpharma Brand of Cinnarizine API manufacturers, exporters, distributors and traders.
click here to find a list of Alpharma Brand of Cinnarizine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Alpharma Brand of Cinnarizine DMF (Drug Master File) is a document detailing the whole manufacturing process of Alpharma Brand of Cinnarizine active pharmaceutical ingredient (API) in detail. Different forms of Alpharma Brand of Cinnarizine DMFs exist exist since differing nations have different regulations, such as Alpharma Brand of Cinnarizine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Alpharma Brand of Cinnarizine DMF submitted to regulatory agencies in the US is known as a USDMF. Alpharma Brand of Cinnarizine USDMF includes data on Alpharma Brand of Cinnarizine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Alpharma Brand of Cinnarizine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Alpharma Brand of Cinnarizine suppliers with USDMF on PharmaCompass.
A Alpharma Brand of Cinnarizine CEP of the European Pharmacopoeia monograph is often referred to as a Alpharma Brand of Cinnarizine Certificate of Suitability (COS). The purpose of a Alpharma Brand of Cinnarizine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Alpharma Brand of Cinnarizine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Alpharma Brand of Cinnarizine to their clients by showing that a Alpharma Brand of Cinnarizine CEP has been issued for it. The manufacturer submits a Alpharma Brand of Cinnarizine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Alpharma Brand of Cinnarizine CEP holder for the record. Additionally, the data presented in the Alpharma Brand of Cinnarizine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Alpharma Brand of Cinnarizine DMF.
A Alpharma Brand of Cinnarizine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Alpharma Brand of Cinnarizine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Alpharma Brand of Cinnarizine suppliers with CEP (COS) on PharmaCompass.
A Alpharma Brand of Cinnarizine written confirmation (Alpharma Brand of Cinnarizine WC) is an official document issued by a regulatory agency to a Alpharma Brand of Cinnarizine manufacturer, verifying that the manufacturing facility of a Alpharma Brand of Cinnarizine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Alpharma Brand of Cinnarizine APIs or Alpharma Brand of Cinnarizine finished pharmaceutical products to another nation, regulatory agencies frequently require a Alpharma Brand of Cinnarizine WC (written confirmation) as part of the regulatory process.
click here to find a list of Alpharma Brand of Cinnarizine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Alpharma Brand of Cinnarizine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Alpharma Brand of Cinnarizine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Alpharma Brand of Cinnarizine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Alpharma Brand of Cinnarizine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Alpharma Brand of Cinnarizine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Alpharma Brand of Cinnarizine suppliers with NDC on PharmaCompass.
Alpharma Brand of Cinnarizine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alpharma Brand of Cinnarizine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alpharma Brand of Cinnarizine GMP manufacturer or Alpharma Brand of Cinnarizine GMP API supplier for your needs.
A Alpharma Brand of Cinnarizine CoA (Certificate of Analysis) is a formal document that attests to Alpharma Brand of Cinnarizine's compliance with Alpharma Brand of Cinnarizine specifications and serves as a tool for batch-level quality control.
Alpharma Brand of Cinnarizine CoA mostly includes findings from lab analyses of a specific batch. For each Alpharma Brand of Cinnarizine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alpharma Brand of Cinnarizine may be tested according to a variety of international standards, such as European Pharmacopoeia (Alpharma Brand of Cinnarizine EP), Alpharma Brand of Cinnarizine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alpharma Brand of Cinnarizine USP).
Comment (3)
